Maxi Investments CY Ltd Makes New $1.66 Million Investment in Danaher Corporation $DHR

Maxi Investments CY Ltd acquired a new stake in shares of Danaher Corporation (NYSE:DHR) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 2,300 shares of the conglomerate’s stock, valued at approximately $1,656,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Portland Investment Counsel Inc. purchased a new position in Danaher during the 2nd quarter valued at about $11,934,000. Cibc World Market Inc. purchased a new stake in Danaher in the second quarter worth about $31,830,000. Satovsky Asset Management LLC purchased a new stake in Danaher in the second quarter worth about $355,000. Blue Whale Capital LLP bought a new position in shares of Danaher during the second quarter valued at approximately $17,508,000. Finally, OMERS ADMINISTRATION Corp purchased a new position in shares of Danaher during the second quarter valued at approximately $6,729,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Stock Performance

DHR stock opened at $219.42 on Monday. The stock’s 50 day simple moving average is $195.80 and its 200 day simple moving average is $192.40. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The stock has a market capitalization of $154.25 billion, a PE ratio of 38.97, a price-to-earnings-growth ratio of 2.72 and a beta of 0.78.

Danaher (NYSE:DHR) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The business had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter last year, the company earned $0.77 EPS. As a group, research analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Evercore reissued an “outperform” rating and issued a $230.00 price target on shares of Danaher in a research report on Monday, July 6th. Piper Sandler initiated coverage on Danaher in a research report on Thursday, June 11th. They set a “neutral” rating and a $200.00 price objective for the company. DZ Bank initiated coverage on Danaher in a research note on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price objective for the company. HSBC dropped their target price on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. Finally, Weiss Ratings raised Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 15th. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, Danaher currently has an average rating of “Moderate Buy” and an average target price of $228.91.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.